Evidence map›Paper›PMID 31784048›Full record

ArticleKidney international2020

A collagen-binding protein enables molecular imaging of kidney fibrosis in vivo.

Maike Baues, Barbara M Klinkhammer, Josef Ehling, Felix Gremse, Marc A M J van Zandvoort, Chris P M Reutelingsperger, Christoph Daniel, Kerstin Amann, Janka Bábíčková, Fabian Kiessling and 3 more

Abstract read
In one paragraph

Article in Kidney international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Nanoparticles in the Treatment of Renal Fibrosis.International journal of nanomedicine · 2026
    Review
  6. Review
  7. Review
  8. Around the collagen triple helix: an introduction to studying associated genetic and acquired diseases.Matrix biology : journal of the International Society for Matrix Biology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. TRPML-1 Dysfunction and Renal Tubulopathy in Mucolipidosis Type IV.Journal of the American Society of Nephrology : JASN · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Maike BauesInstitute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Aachen, Germany.
Barbara M KlinkhammerInstitute of Pathology, RWTH Aachen University Hospital, Aachen, Germany; Department of Nephrology and Immunology, RWTH Aachen University Hospital, Aachen, Germany.
Josef EhlingInstitute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Aachen, Germany; Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany.
Felix GremseInstitute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Aachen, Germany.
Marc A M J van ZandvoortDepartment of Biochemistry, University Hospital Maastricht (azM), Maastricht, The Netherlands.
Chris P M ReutelingspergerDepartment of Pathology, Electron Microscopy Unit, University of Maastricht, Maastricht, The Netherlands.
Christoph DanielInstitute of Pathology, University Erlangen, Erlangen, Germany.
Kerstin AmannInstitute of Pathology, University Erlangen, Erlangen, Germany.
Janka BábíčkováDepartment of Nephrology and Immunology, RWTH Aachen University Hospital, Aachen, Germany; Institute of Molecular Biomedicine, Comenius University, Bratislava, Slovakia; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Fabian KiesslingInstitute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Aachen, Germany.
Jürgen FloegeDepartment of Nephrology and Immunology, RWTH Aachen University Hospital, Aachen, Germany.
Twan LammersInstitute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Aachen, Germany; Department of Pharmaceutics, Utrecht University, Utrecht, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede, The Netherlands. Electronic address: tlammers@ukaachen.de.
Peter BoorInstitute of Pathology, RWTH Aachen University Hospital, Aachen, Germany; Department of Nephrology and Immunology, RWTH Aachen University Hospital, Aachen, Germany; Electron Microscopy Facility, RWTH Aachen University Hospital, Aachen, Germany. Electronic address: pboor@ukaachen.de.

Funding

European Research Council 813086
6 · The paper itself

Abstract

Pathological deposition of collagen is a hallmark of kidney fibrosis. To illustrate this process we employed multimodal optical imaging to visualize and quantify collagen deposition in murine models of kidney fibrosis (ischemia-reperfusion or unilateral ureteral obstruction) using the collagen-binding adhesion protein CNA35. For in vivo imaging, we used hybrid computed tomography-fluorescence molecular tomography and CNA35 labeled with the near-infrared fluorophore Cy7. Upon intravenous injection, CNA35-Cy7 accumulation was significantly higher in fibrotic compared to non-fibrotic kidneys. This difference was not detected for a non-specific scrambled version of CNA35-Cy7. Ex vivo, on kidney sections of mice and patients with renal fibrosis, CNA35-FITC co-localized with fibrotic collagen type I and III, but not with the basement membrane collagen type IV. Following intravenous injection, CNA35-FITC bound to both interstitial and perivascular fibrotic areas. In line with this perivascular accumulation, we observed significant perivascular fibrosis in the mouse models and in biopsy sections from patients with chronic kidney disease using computer-based morphometry quantification. Thus, molecular imaging of collagen using CNA35 enabled specific non-invasive quantification of kidney fibrosis. Collagen imaging revealed significant perivascular fibrosis as a consistent component next to the more commonly assessed interstitial fibrosis. Our results lay the basis for further probe and protocol optimization towards the clinical translation of molecular imaging of kidney fibrosis.

Indexed as

Carrier ProteinsUreteral ObstructionAnimalsCollagenFibrosisHumansKidneyMiceMolecular ImagingCarrier ProteinsCollagenchronic kidney disease (CKD)collagenextracellular matrixmolecular imagingnon-invasive imagingrenal fibrosis

Identifiers

PMID31784048
PMCPMC7115881

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.